Simply Credit Help – Debt and Bad Credit Improvement Advice
patents-related

Lockheed gets $1.5 billion deal for C-130J aircraft: Pentagon

March 26, 2016 by · Leave a Comment 

WASHINGTON (Reuters) – Lockheed Martin Corp has won a contract worth $1.5 billion for work on 28 C-130J military transport aircraft funded by the fiscal 2016 defense budget, the Pentagon said on Thursday in its daily digest of major contracts.

More:
Lockheed gets $1.5 billion deal for C-130J aircraft: Pentagon

patents-related

Credit Suisse to pay $29 million in U.S. regulator’s mortgage case

March 26, 2016 by · Leave a Comment 

Credit Suisse Group AG has agreed to pay more than $29 million to resolve a U.S. regulator's claims that it sold toxic mortgage-backed securities to credit unions that later failed, according to court papers filed on Thursday. The deal, disclosed in a filing in federal court in Manhattan, …

Original post: 
Credit Suisse to pay $29 million in U.S. regulator’s mortgage case

patents-related

U.S. extends BMW deadline to get replacement air bag inflators

March 26, 2016 by · Leave a Comment 

BMW AG will get five more months to acquire Takata air bag replacement parts for a massive recall because tests showed some of the substitute inflators may also be defective, the U.S. auto safety agency said on Thursday. The deadline for the German automaker was extended to Aug. 31 because a replacement driver-side air bag inflator made by a supplier other than Takata failed during testing

Original post: 
U.S. extends BMW deadline to get replacement air bag inflators

patents-related

Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute

March 26, 2016 by · Leave a Comment 

SAN JOSE, Calif.,/NEW YORK (Reuters) – A federal jury on Thursday ordered Gilead Sciences Inc to pay Merck & Co $200 million in damages for infringing two Merck patents related to a lucrative cure for hepatitis C. The damages award is far less than the $2 billion Merck had demanded. On Tuesday, the same jury in San Jose, California, upheld the validity of the patents, which

Here is the original post:
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute